The cost of prescriptions for multiple sclerosis (MS) drugs nearly tripled over seven years, and the introduction of a generic version of one of the most common drugs had little overall effect on prices, according to a study published in the Jan. 15, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Source: Study: MS drug costs nearly triple over 7 years, even with introduction of generic
‹ Exposure to chemicals in drinking water associated with 5% of annual bladder cancer burden in Europe
Categories: Misc....
Coronavirus variants predicts virus evolving to escape current vaccines, and allergic reactions + 
B6 may help keep COVID-19’s cytokine storms at bay 
Vitamin B6 may help keep COVID-19’s cytokine storms at bay, vaccines may cause mammograms false positives plus Data 